Loading candles…
Emami Ltd., incorporated in 1974 and headquartered in Kolkata, West Bengal, India, is a manufacturer and marketer of personal care and healthcare products. The company operates primarily within the fast-moving consumer goods (FMCG), personal care, healthcare, and Ayurvedic and herbal products industries. Emami's portfolio includes over 550 products, featuring well-known brands such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, and Mentho Plus Balm. It specializes in Ayurvedic and herbal formulations and holds significant market positions in antiseptic creams, cooling oils, and pain balms. Emami serves more than 5.4 million retail outlets across India and markets its products in over 70 countries globally.
This page is a live market overview for EMAMI LIMITED (EMAMILTD) on the NSE. As a listed security, EMAMI LIMITED is tracked in the Fast Moving Consumer Goods segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for EMAMILTD before placing trades on tick2trade.
As of the latest feed, EMAMILTD last traded at ₹409.55 on NSE, down ₹3 (0.73%) from the previous close of ₹412.55. Today's session range is ₹408.35 – ₹414.7, against a 52-week band of ₹376.4 – ₹634.2. Traded volume today stands at 3.21L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for EMAMILTD in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether EMAMILTD is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for EMAMI LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in EMAMILTD. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated EMAMILTD option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 4 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 21 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025, dividend and other business matters | 4 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters | 10 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters | 31 Jul 2025 |
| Audited Results - Q4 & FY25 | To consider and approve audited standalone and consolidated financial results of the company for the fourth quarter and Financial Year ended 31st March, 2025 | 16 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.